What: grants for proposals on the development of therapeutics and diagnostics to tackle current and future coronavirus outbreaks. The budget of the call is 45 million €. IMI is looking for proposals that address:
- The development of treatments to rapidly respond to the current COVID-19 outbreak and/or future coronavirus outbreaks – this could include potential drugs that are already at a very advanced stage of development, or an existing, approved drug that could be ‘repurposed’ to treat COVID-19. It could also include drugs that are in the earlier stages of development, as well as strategies to address drug resistance;
- The development of diagnostic tests to rapidly and reliably identify people infected with the coronavirus that causes COVID-19, and for use in clinical trials of new drugs.
Preventive vaccines are specifically excluded from the call.
For whom: The call is addressed to consortia and organisations such as:
- universities and public research institutions
- small and medium enterprises
- companies with an annual turnover up to EURO 500 million
- hospitals and health care organisations
- no profit organisations
How to apply: Applications should be submitted via this websites
Deadline: 31st March 2020
Organizer: The Innovative Medicines Initiative. IMI is the world’s biggest public-private partnership in the life sciences. It is a partnership between the European Union and the European pharmaceutical industry
More details are available on the website
source: European Innovation Council